Oculus Innovative Sciences, Inc. (OCLS) Receives Chinese SFDA Regulatory Approval of Microcyn(R) Hydrogel

7/10/2012 9:32:33 AM

PETALUMA, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that the Chinese State Food and Drug Administration (SFDA) has approved Microcyn® Hydrogel for moistening, repairing and healing of acute and chronic wounds in China. This approval allows Oculus' Chinese partner, Shanghai Sunvic, to market Microcyn Hydrogel in both the over-the-counter and professional healthcare markets in China. Shanghai Sunvic plans to launch the Microcyn hydrogel in the third quarter of 2012.

Read at GlobeNewswire

Read at ChinaBio Today

Read Article at

Related Companies

News Categories

• GlobeNewswire

• ChinaBio Today

• Oculus Innovative Sciences, Inc.

• SFDA

• Medical Dev. & Diag. - Approvals

• Medical Devices